Knowledge, Skill and Passion Graphic Goes Here - 385px by 95px



Michael Vileikis

Director, Process Technology

OSD and Sterile Expert

Areas of Expertise

  • Oral Solid Dosage Manufacturing
  • Potent Material Handling / Containment Design
  • Critical Utilities
  • Isolation Technology
  • Process Engineering
  • Equipment Coordination
  • Technical Consultancy
  • Risk Assessment


I enjoy the challenge of helping my client meet their business and engineering needs while adhering to regulatory and industry standards.

- Michael Vileikis
Director, Process Technology

Mr. Vileikis has more than two decades of experience in the pharmaceutical and biotechnology industries. Michael offers a broad range of technical knowledge and skill, specifically in the areas of process system design, containment and material handling strategies,  equipment specification and utility system design. Michael adds value to all phases of a project from concept/feasibility to detail design and through construction administration.

Mr. Vileikis’s experience with OSD manufacturing, aseptic/sterile filling and biotechnology facilities have allowed him to develop a depth of knowledge of the equipment, processes, operations and material handling requirements associated with these facilities.

Michael has been involved in the organization and execution of the IPS OSD tours at Interphexfor the last three years.  His recent publications include:

"Handling Hidden Scale-Up Hazards", Pharmaceutical Processing, February 2014.

Should it be Scale-up or Scale Out…Bigger is Not Always Better or Faster”, 1st Annual Oral Solid Dosage Technologies Tour, INTERPHEX, New York, NY, May 2012.

By sending us an email, you agree to our privacy policy.

  • p. 888.366.7660

Recent Projects

  • Detail design of a generic OSD manufacturing facility expansion to double capacity
  • Development scale ADC lab renovation with highly potent material handling
  • Fluid bed and granulation risk evaluation (transition of new potent processing into existing equipment)
  • OSD facility expansion master plan including hormonal and cytotoxic manufacturing
  • ISPE OSD Baseline Guide update